Impax Laboratories, Inc. IPXL today announced that the Company will present at the 31st Annual J.P. Morgan Healthcare Conference on Monday, January 7, at 3:00 p.m. Pacific Standard Time. The conference will be held at the Westin St. Francis Hotel, San Francisco, CA.
Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at www.impaxlabs.com. This presentation will be archived on the Company's web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax is headquartered in Hayward, California, and has a full range of capabilities in its Hayward, Philadelphia and Taiwan facilities. For more information, please visit the Company's Web site at: www.impaxlabs.com.
Impax Laboratories, Inc.
Sr. Director, Investor Relations and Corporate Communications
Mark Donohue, 215-558-4526
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.